Literature DB >> 11013452

Identification and characterization of two novel mutations that produce acute intermittent porphyria: A 3-base deletion (841-843delGGA) and a missense mutation (T35M).

A De Siervi1, D E Weiss Cádiz, V E Parera, A M del C Batlle, M V Rossetti.   

Abstract

A partial deficiency of Porphobilinogen deaminase (PBGD) is responsible for acute intermittent porphyria (AIP). AIP is inherited in an autosomal dominant fashion, and the prevalence in the Argentinean population is about 1:125,000. Here, two new mutations and two previously reported were found in the PBGD gene in 22 Argentinean AIP patients corresponding to 8 different families. To screen for AIP mutations in symptomatic patients, genomic DNA isolated was amplified in 6 PCR reactions, then all coding exons and flanking intronic regions were sequenced. The novel mutations are 841-843delGGA in exon 14, which results in the loss of glycine-281 (G281del), and one 104C>T point mutation in the exon 4 (T35M). To further characterize both novel mutations, the pKK-PBGD construct for the mutant alleles were expressed in E. coli, the enzymatic activity of the recombinant proteins were 1% and 4% of the mean level expressed by the normal allele for 841-843delGGA and T35M, respectively. Hum Mutat 16:373, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013452     DOI: 10.1002/1098-1004(200010)16:4<373::AID-HUMU14>3.0.CO;2-A

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

1.  Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.

Authors:  Sonia Clavero; David F Bishop; Mark E Haskins; Urs Giger; Raili Kauppinen; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2009-11-24       Impact factor: 6.150

2.  Porphobilmogen deaminase gene mutations in Brazilian acute intermittent porphyria patients.

Authors:  Georgina Severo Ribeiro; Paulo Eurípedes Marchiori; Paula Marzorati Kuntz Puglia; Maria Aparecida Nagai; Mariana Lopes Dos Santos; Kimiyo Nonoyama; Mário Hiroyuki Hirata; Orlando C O Barretto
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Acute intermittent porphyria in Argentina: an update.

Authors:  Gabriela Nora Cerbino; Esther Noemí Gerez; Laura Sabina Varela; Viviana Alicia Melito; Victoria Estela Parera; Alcira Batlle; María Victoria Rossetti
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 4.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.